Literature DB >> 21645356

The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Leslee Sprague1, Maria Muccioli, Michelle Pate, Evan Meles, John McGinty, Harika Nandigam, Amritha K Venkatesh, Ming-Yu Gu, Kristen Mansfield, Andrew Rutowski, Omowaleola Omosebi, Maria C Courreges, Fabian Benencia.   

Abstract

BACKGROUND: Dendritic cells (DCs) are antigen presenting cells capable of inducing specific immune responses against microbial infections, transplant antigens, or tumors. Interestingly, microenvironment conditions such as those present in tumor settings might induce a DC phenotype that is poorly immunogenic and with the capability of promoting angiogenesis. We hypothesize that this plasticity may be caused not only by the action of specific cytokines or growth factors but also by the properties of the surfaces with which they interact, such as extracellular matrix (ECM) components.
RESULTS: Herewith we studied the effect of different surfaces and soluble factors on the biology of DCs. To accomplish this, we cultured murine myeloid(m) DCs on surfaces coated with fibronectin, collagen I, gelatin, and Matrigel using poly-D-lysine and polystyrene as non-biological surfaces. Further, we cultured these cells in the presence of regular DC medium (RPMI 10% FBS) or commercially available endothelial medium (EGM-2). We determined that mDCs could be kept in culture up to 3 weeks in these conditions, but only in the presence of GM-CSF. We were able to determine that long-term DC cultures produce an array of angiogenic factors, and that some of these cultures still retain the capability to induce T cell responses.
CONCLUSIONS: Altogether these data indicate that in order to design DC-based vaccines or treatments focused on changing the phenotype of DCs associated with diseases such as cancer or atherosclerosis, it becomes necessary to fully investigate the microenvironment in which these cells are present or will be delivered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645356      PMCID: PMC3124423          DOI: 10.1186/1471-2172-12-35

Source DB:  PubMed          Journal:  BMC Immunol        ISSN: 1471-2172            Impact factor:   3.615


  72 in total

Review 1.  Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.

Authors:  U Yrlid; M Svensson; C Johansson; M J Wick
Journal:  FEMS Immunol Med Microbiol       Date:  2000-04

Review 2.  PSGL-1 function in immunity and steady state homeostasis.

Authors:  Douglas A Carlow; Klaus Gossens; Silvia Naus; Krystle M Veerman; Wooseok Seo; Hermann J Ziltener
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

3.  Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation.

Authors:  Fabian Benencia; Maria C Courrèges; Nigel W Fraser; George Coukos
Journal:  Cancer Biol Ther       Date:  2008-08-01       Impact factor: 4.742

4.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Authors:  Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

5.  Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

Authors:  Eduardo Huarte; Juan R Cubillos-Ruiz; Yolanda C Nesbeth; Uciane K Scarlett; Diana G Martinez; Ronald J Buckanovich; Fabian Benencia; Radu V Stan; Tibor Keler; Pablo Sarobe; Charles L Sentman; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2008-09-03       Impact factor: 12.701

6.  Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus.

Authors:  Yuri V Bobryshev; Dinh Tran; Murray C Killingsworth; Michael Buckland; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2008-11-18       Impact factor: 3.452

Review 7.  T-cell costimulation and coinhibition in atherosclerosis.

Authors:  Israel Gotsman; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

8.  Heparanase induces endothelial cell migration via protein kinase B/Akt activation.

Authors:  Svetlana Gingis-Velitski; Anna Zetser; Moshe Y Flugelman; Israel Vlodavsky; Neta Ilan
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain.

Authors:  Matthias Schweizerhof; Sebastian Stösser; Martina Kurejova; Christian Njoo; Vijayan Gangadharan; Nitin Agarwal; Martin Schmelz; Kiran Kumar Bali; Christoph W Michalski; Stefan Brugger; Anthony Dickenson; Donald A Simone; Rohini Kuner
Journal:  Nat Med       Date:  2009-06-07       Impact factor: 53.440

Review 10.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

View more
  13 in total

1.  Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process.

Authors:  Giselles Acevedo; Nischal K Padala; Li Ni; G M Jonakait
Journal:  J Neurochem       Date:  2013-03-27       Impact factor: 5.372

2.  To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices.

Authors:  Luis M Delgado; Yves Bayon; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Tissue Eng Part B Rev       Date:  2015-03-12       Impact factor: 6.389

3.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

Review 4.  The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity.

Authors:  Nils Scheib; Jessica Tiemann; Christian Becker; Hans Christian Probst; Verena Katharina Raker; Kerstin Steinbrink
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

5.  Absence of immune responses with xenogeneic collagen and elastin.

Authors:  Alexandra Bayrak; Pauline Prüger; Ulrich A Stock; Martina Seifert
Journal:  Tissue Eng Part A       Date:  2013-04-15       Impact factor: 3.845

6.  Fast-proliferating adipose tissue mesenchymal-stromal-like cells for therapy.

Authors:  Elisabet Aguilar; Julio Rodriguez Bagó; Carol Soler-Botija; Maria Alieva; Maria Angeles Rigola; Carme Fuster; Olaia F Vila; Nuria Rubio; Jeronimo Blanco
Journal:  Stem Cells Dev       Date:  2014-08-13       Impact factor: 3.272

7.  Ovarian dendritic cells act as a double-edged pro-ovulatory and anti-inflammatory sword.

Authors:  Adva Cohen-Fredarow; Ari Tadmor; Tal Raz; Naama Meterani; Yoseph Addadi; Nava Nevo; Inna Solomonov; Irit Sagi; Gil Mor; Michal Neeman; Nava Dekel
Journal:  Mol Endocrinol       Date:  2014-05-13

8.  Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization.

Authors:  Arun H S Kumar; Kenneth Martin; Elizebeth C Turner; Chirlei K Buneker; Karim Dorgham; Philippe Deterre; Noel M Caplice
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 9.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15

10.  Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Authors:  Jared S Klarquist; Edith M Janssen
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.